Showing: 1 - 2 of 2 RESULTS

Allergy Immunotherapies Market – Actionable Research on COVID-19 | Increasing Prevalence of Allergies to Boost the Market Growth

The global allergy immunotherapies market size is poised to grow by USD 626.77 million during 2020-2024, progressing at a CAGR of about 7% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Download a Free Sample of REPORT with COVID-19 Crisis and Recovery Analysis.

This press release features multimedia. View the full release here:

Technavio has announced its latest market research report titled Global Allergy Immunotherapies Market 2020-2024 (Graphic: Business Wire).

The increasing prevalence of allergies is driving the need for allergy immunotherapies. Allergies are regarded as one of the most common ailments, affecting more than 500 million people around the world. The rising incidence of allergy is triggered by factors such as the growing pollution and increased consumption of tobacco products like cigarettes. Moreover, a large portion of people are affected multiple times due to the non-remissive nature of the allergy. The huge unmet need for allergy treatment globally has led to various vendors conducting research on novel therapies, resulting in advances in the field of immunology therapeutics for allergies.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Report Highlights:

  • The major allergy immunotherapies market growth came from SCIT segment. It was the largest product segment of the allergy immunotherapies market in 2019, mainly because of the high efficiency for the treatment of various respiratory allergies. Additionally, SCITs are administered in simple and standardized doses, and they result in long-lasting symptom relief. Thus, contributing to the growth of the market in focus.

  • Europe had the largest allergy immunotherapies market share in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The high prevalence of allergies will significantly influence allergy immunotherapies market growth in this region.

  • The global allergy immunotherapies market is concentrated. Aimmune Therapeutics Inc., ALK-Abell√≥ AS, Allergy Therapeutics Plc, ASIT Biotech SA, DBV Technologies SA, HAL Allergy BV, Jubilant Life Sciences Ltd., Laboratorios LETI SLU, Merck KGaA, and Stallergenes Greer Plc. are some of the major market participants. To help clients improve their market position, this allergy immunotherapies market forecast report provides a detailed analysis of the market leaders.

  • As the business impact of COVID-19 spreads, the global allergy immunotherapies market 2020-2024 is expected to have Neutral and At par growth. As the pandemic spreads in some regions and plateaus in other regions, we revaluate the impact on businesses and update our report forecasts.

Read the full report here:

Presence of a Strong Pipeline for Allergy Immunotherapy and the Estimated New Approvals will be a Key Market Trend

The strong efficacy and relatively higher safety of allergy immunotherapies combined with a strong prevalence of various allergies create an attractive opportunity for the market players. Hence, several pharmaceutical and biotechnology

Plan Ahead to Keep Halloween Safe for Kids With Asthma, Allergies | Health News

By Robert Preidt, HealthDay Reporter


TUESDAY, Oct. 6, 2020 (HealthDay News) — This Halloween may be especially challenging for parents of children with asthma and allergies, as they also have to guard against COVID-19.

“Every year we send out tips on how to keep your kids with allergies and asthma symptom-free as they celebrate one of their favorite holidays,” said allergist Dr. J. Allen Meadows, president of the American College of Allergy, Asthma and Immunology (ACAAI).

“This year, along with our usual guidance, we want to point people to the [U.S. Centers for Disease Control and Prevention] and their recommendations for avoiding COVID-19,” Meadows said in a college news release.

As you plan for the holiday, consider these tips from the ACAAI:

If kids are attending events, outdoor activities are always best. Children must wear a mask and maintain social distance. There are Halloween-themed cloth masks that help protect against COVID-19, so kids should be encouraged to choose a costume that works with a protective mask.

An ordinary costume mask is not a substitute for a mask meant to protect against the coronavirus. The CDC says a costume mask should not be worn over a cloth mask if the costume mask makes it hard to breathe.

Try to have Halloween activities around your home, where you can control the environment and the allergens. For example, you can make sure all treats are allergen-free if your child suffers from a food allergy.

Ideas for at-home fun include pumpkin carving, having a costume parade over Zoom, or a scavenger hunt in the house or yard with family members.

If your child does go trick-or-treating, the CDC recommends a one-way approach where individual goodie bags are lined up for families to grab at the end of a driveway or edge of a yard.

If you’re preparing goodie bags, make sure to wash your hands with soap and water for at least 20 seconds before and after preparing the bags. If your child goes trick-or-treating, check their bag for any candy that might contain food allergens.

If your child with allergies or asthma is attending a Halloween event or going one-way trick or treating, make sure they have their supplies with them.

Children with asthma should carry their inhaler because kicking up moldy leaves can cause asthma symptoms. If a child has a food allergy, they shouldn’t leave home without their epinephrine auto injector, in case they sneak a treat that contains a possible allergen.

Copyright © 2020 HealthDay. All rights reserved.

Source Article